Skip to Content

INCY 25 (Jakafi 25 mg)

Generic Name: ruxolitinib

Pill with imprint INCY 25 is White, Elliptical / Oval and has been identified as Jakafi 25 mg. It is supplied by Incyte Corporation.

Jakafi is used in the treatment of myelofibrosis; myeloproliferative disorders; polycythemia vera and belongs to the drug class multikinase inhibitors. Risk cannot be ruled out during pregnancy. Jakafi 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for INCY 25

Jakafi

Generic Name:
ruxolitinib
Imprint:
INCY 25
Strength:
25 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Incyte Corporation
National Drug Code (NDC):
50881-0025

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide